RxDoctor Payments Data

Jaime Cunningham

Family · Richmond, VANPI 1285053678

Payments from drug & device makers

$1,624in general payments, 2019–2025

Across 96 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$392
  • Amgen$209
  • Lilly USA, LLC$141
  • AbbVie$114
  • Pfizer$90
  • Abbott$70
  • plus $608 from 24 others

What the payments were for

  • Food & beverage$1,60599%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,624 in reported general payments places this provider in the 80th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$50,519
Medicare patients
637
Services billed
904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium67$877
Metoprolol Succinate44$810
Methylprednisolone119$793
Duloxetine Hcl30$714
Omeprazole37$629
Pregabalin12$608
Doxycycline Hyclate51$513
ValacyclovirValacyclovir Hcl11$467
Levothyroxine Sodium42$349
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav55$339
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst45$326
Pantoprazole Sodium26$317
Losartan Potassium23$304
Metformin Hcl ErMetformin Hcl12$287
Amlodipine Besylate46$246

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$90$016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,332 family providers in Virginia.

Other family in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →